Imagine — weight loss just a breath away
We are developing a simple weekly inhalation therapy — making gold-standard weight loss treatment more convenient, more accessible, and more affordable.
The problem
Effective obesity drugs exist. Most patients never receive them — or stop taking them
Less than 1% of people living with obesity receive treatment. Not because the drugs don’t work — but because invasive injections and daily tablets with strict fasting protocols are inconvenient, and the cost is simply out of reach for most people.
Convenience
Injections are invasive and burdensome. Daily tablets require strict fasting protocols. Both contribute to treatment fatigue and high discontinuation rates.
Cost
Injectables rely on complex manufacturing and cold-chain logistics. Oral formulations require large drug doses. Both drive costs that are unaffordable for most patients globally.
Our approach
A new way to deliver the world's most effective weight loss medicines
- Non-invasive
- Once-weekly
- Low cost
- Built on approved medicines
We are developing a pulmonary delivery platform for gold-standard peptide-based obesity medicines. By combining advances in particle engineering with a clinically validated absorption enhancer, we aim to achieve bioavailability above 30% — enabling tolerable once-weekly dosing from a single inhalation.
Our scalable dry powder technology is designed to significantly reduce the cost of goods compared to both injectables and oral formulations — making effective obesity medicines more affordable and accessible to patients globally.